510(k) K961476
K961476 is an FDA 510(k) premarket notification submitted by Salter Labs for the device "SALTERLABS 8960 SERIES NEBULIZER (8960/8961/8966/8984)". The FDA issued a decision of Substantially Equivalent on July 16, 1996. The device falls under product code CAF (Nebulizer (Direct Patient Interface)), a Class II device regulated under 21 CFR 868.5630. Salter Labs has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 16, 1996
- Date Received
- April 18, 1996
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Nebulizer (Direct Patient Interface)
- Device Class
- Class II
- Regulation Number
- 868.5630
- Review Panel
- AN
- Submission Type